HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Physiol. Genomics 31: 343-351, 2007. First published July 24, 2007; doi:10.1152/physiolgenomics.00080.2007
1094-8341/07 $8.00

This Article Free upon publication Full Text Full Text (PDF) Supplemental Tables All Versions of this Article: 31/2/343    most recent 00080.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Zer, C. Articles by Shin, J. M. Search for Related Content PubMed PubMed Citation Articles by Zer, C. Articles by Shin, J. M.

Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor- signaling

Department of Physiology, David Geffen School of Medicine, University of California at Los Angeles and Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California

Inhibition of p38 MAPK suppresses the expression of proinflammatory cytokines such as TNF- and IL-1ß in macrophages and fibroblast-like synoviocytes (FLS). However, there have been no genomewide studies on the gene targets of p38 MAPK signaling in synoviocytes. Microarray technology was applied to generate a comprehensive analysis of all genes regulated by the p38 MAPK signaling pathway in FLS. Gene expression levels were measured with Agilent oligonucleotide microarrays. Four independent sets of mRNA modulated by TNF- and vehicle were used to measure the change of gene expression due to TNF-, and three experiments were done to ascertain the effect of SB-203580, a p38 MAPK inhibitor, on TNF--induced genes. Microarray data were validated by RT-quantitative polymerase chain reaction. One hundred forty-one significantly expressed genes were more than twofold upregulated by TNF-. Thirty percent of these genes were downregulated by the p38 inhibitor SB-203580, whereas 67% of these genes were not significantly changed. The SB-203580-inhibited genes include proinflammatory cytokines such as interleukins and chemokines, proteases including matrix metallopeptidases, metabolism-related genes such as cyclooxygenases and phosphodiesterase, genes involved in signal transduction, and genes encoding for transcription factors, receptors, and transporters. Approximately one-third of the TNF--induced genes in FLS are regulated by the p38 MAPK signal pathway, showing that p38 MAPK is a possible target for suppressing proinflammatory gene expressions in rheumatoid arthritis.

microarray; synoviocytes; SB-203580; rheumatoid arthritis